The longevity industry has emerged from a fragmented and disjointed set of research fields, progressing from a curiosity-driven exploration of aging to a burgeoning commercial sector. This article explores the early inertia and misframing that delayed the longevity industry’s maturation, particularly how aging was initially viewed as a distant, insurmountable challenge rather than a series of manageable biological damages. The lack of a coherent framework for integrating diverse scientific, technological, and financial components slowed progress, preventing synergy between disciplines. However, as the sector evolved, a new vision began to take shape—one that reframed aging as a series of cumulative damages that could be repaired with regenerative medicine and biotechnology. This shift laid the groundwork for longevity industrialization. The paper emphasizes the importance of establishing comprehensive, data-driven frameworks to avoid the inertia of the past. By integrating policy, finance, and science, future progress can be accelerated, ensuring that longevity technologies reach their full potential in improving global health and economy. Through coordinated governance and cross-sector collaboration, the longevity industry can transition from fragmented research to a fully operational global sector.